基于子组识别的模型选择,以提高个性化剂量的预测性能
Hiie Soeorg1, Riste Kalamees2, Irja Lutsar2
1Department of Microbiology, University of Tartu, Ravila 19, Tartu, 50411, Estonia. hiie.soeorg@ut.ee.
Journal of pharmacokinetics and pharmacodynamics
|February 24, 2024
概括
在新生儿/婴儿中开发出用于万科米辛剂量的子组识别方法,改善了基于模型的精确剂量预测. 这种方法提高了个性化剂量准确性,而不是使用单一最适合的药理动力学模型.
科学领域:
- 制药指标 (Pharmacometrics) 是一个指标.
- 儿科药理学 儿科药理学
- 计算生物学 计算生物学
背景情况:
- 基于模型的精确剂量 (MIPD) 目前依赖于单个种群的药理动力学模型.
- 优化个性化剂量需要对特定患者子组进行更好的预测性能.
研究的目的:
- 开发和评估基于子组识别的模型选择方法,用于精确剂量.
- 为了提高新生儿和婴儿的万科米辛剂量的预测性能.
主要方法:
- 使用了新生儿/婴儿中万科米辛度的培训和测试数据集.
- 从已发表的药理动力学模型中计算出人口预测.
- 采用聚类和遗传算法来识别子组和选择模型.
- 开发了分类树,以预测个人患者的最佳表现模型.
主要成果:
- 单一表现最好的模型在测试数据集中显示出有限的预测性能 (P20:26.2-42.6%).
- 提出的子组识别方法实现了更好的预测性能 (P20:44.1-45.5%).
- 在60% (P60) 内的预测的百分比在不同方法之间是可比的.
结论:
- 基于子组识别的模型选择有可能提高精确剂量准确性.
- 这种方法提供了一个有希望的替代方案,以单一最适合的模型策略在儿科万科米辛治疗.
- 需要进一步验证,以确认这种新方法的临床实用性.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
73
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
73
Analysis of Population Pharmacokinetic Data
256
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
256
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
127
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
127
Model Approaches for Pharmacokinetic Data: Compartment Models
98
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
98


